Cargando…
Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers
SIMPLE SUMMARY: The place of Next-Generation-Sequencing (NGS) targeted panel in routine practice in digestive oncology should be addressed. The aim of our retrospective study was to assess the results and impact of NGS panel for metastatic colorectal cancer (mCRC) patients. In total, 210 patients wi...
Autores principales: | Bayle, Arnaud, Basile, Debora, Garinet, Simon, Rance, Bastien, Laurent-Puig, Pierre, Blons, Hélène, Taieb, Julien, Perkins, Geraldine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616114/ https://www.ncbi.nlm.nih.gov/pubmed/34830904 http://dx.doi.org/10.3390/cancers13225750 |
Ejemplares similares
-
Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?
por: Garinet, Simon, et al.
Publicado: (2018) -
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
por: Perrier, Alexandre, et al.
Publicado: (2020) -
Ampullary carcinoma prognostic markers
por: Perkins, Geraldine, et al.
Publicado: (2019) -
Exploring the best treatment options for BRAF-mutant metastatic colon cancer
por: Taieb, Julien, et al.
Publicado: (2019) -
A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency
por: Pallet, Nicolas, et al.
Publicado: (2020)